Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Palbociclib (codenamed PD-0332991
.
Show all posts
Showing posts with label
Palbociclib (codenamed PD-0332991
.
Show all posts
Friday, May 27, 2016
Pfizer Receives Expanded FDA Approval For Ibrance (palbociclib) In HR , HER2- Metastatic Breast Cancer
›
Palbociclib (codenamed PD-0332991 , trade name Ibrance ) Pfizer Inc., announced that the U.S. Food and Drug Administration (...
›
Home
View web version
